← Leaderboards
Francesmary Modugno
University Of Pittsburgh At Pittsburgh
$3,651,054
Attributed
$3,651,054
Total exposure
13
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $774.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,651,054 · 13
By mechanism
R21$1,180,647 · 3
P50$1,112,424 · 2
K07$660,992 · 1
R03$371,917 · 3
M01$272,074 · 2
R13$53,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Matthew S Freiberg$20,071,860
- Alison Morris$31,399,077
- Charles R Rinaldo$100,535,685
- Anne B Newman$47,982,910
- Robert A Sweet$35,026,835
Others in their field
Top investigators on “Neoplasm /Cancer Epidemiology”
- Gregory H Reaman · National Childhood Cancer Foundation$140,430,487
- Charles A Coltman · Southwest Oncology Group$46,831,444
- John J Crowley · Fred Hutchinson Cancer Research Center$31,614,221
- Brian E Henderson · University Of Southern California$26,550,422
- William J. Blot · Vanderbilt University$24,199,258
- Walter J Curran · Thomas Jefferson University$17,917,274
Research focus
Neoplasm /Cancer EpidemiologyClinical ResearchOvary NeoplasmsCancer RiskFemaleMalignant NeoplasmsWomanSpecimenBrca GeneBasic ScienceFundingMalignant Neoplasm Of OvaryBioinformaticsHuman TissueCancer Registry /ResourceImproved OutcomeEnvironmentBiometryHuman DataLeadershipCollaborationsCommunitiesBiological Specimen BanksClinic
Grant awards (30)
Multi-omics & AI-based imaging to identify biomarkers of molecular targets for breast cancer prevention$425,573
R21 · FY2025 · CA · contact PI
Core B: TCP: Translational Pathology Core$278,152
P50 · FY2025 · CA · contact PI
CEP: Career Enhancement Program$70,464
P50 · FY2025 · CA · contact PI
Core B: TCP: Translational Pathology Core$322,900
P50 · FY2024 · CA · contact PI
CEP: Career Enhancement Program$75,124
P50 · FY2024 · CA · contact PI
Core B: TCP: Translational Pathology Core$291,849
P50 · FY2023 · CA · contact PI
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and Outcomes$146,330
R21 · FY2023 · CA · contact PI
CEP: Career Enhancement Program$73,935
P50 · FY2023 · CA · contact PI
Multi-omic Predictive Markers for Ovarian Cancer Therapy Response and Outcomes$261,420
R21 · FY2022 · CA · contact PI
Ovarian Cancer: Prevention and Its Recurrence$13,000
R13 · FY2006 · CA · contact PI
HORMONE METABOLISM AND BREAST MASSES$99,930
M01 · FY2005 · RR
Planning Grant for a Study of the Effect of Radiation$74,250
R03 · FY2005 · CA
The Role of Prolactin in Postmenopausal Breast Cancer$74,250
R03 · FY2005 · CA
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS$66,056
K07 · FY2005 · CA
NOVEL RISK FACTOR AND POTENTIAL EARLY DETECT MARK OVARIAN CANCER$50,298
M01 · FY2005 · RR
Ovarian Cancer: Prevention and Its Recurrence$5,000
R13 · FY2005 · CA
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS$138,193
K07 · FY2004 · CA
Hormone Metabolism and Breast Masses$107,092
M01 · FY2004 · RR
The Role of Prolactin in Postmenopausal Breast Cancer$74,250
R03 · FY2004 · CA
Ovarian Cancer: Prevention and Its Recurrence$20,000
R13 · FY2004 · CA
Risk Factor &Potential Early Detection Mark Ovarian Ca$14,754
M01 · FY2004 · RR
Serum Markers of Breast /Ovarian Cancer Risk$172,761
R21 · FY2003 · CA
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS$135,107
K07 · FY2003 · CA
Hormones, DNA Repair, BRCA1/2 and Ovarian Cancer Preven*$74,459
R03 · FY2003 · CA
Serum Markers of Breast /Ovarian Cancer Risk$174,563
R21 · FY2002 · CA
Hormones, DNA Repair, BRCA1/2 and Ovarian Cancer Preven*$74,708
R03 · FY2002 · CA
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS$66,056
K07 · FY2002 · CA
Molecular/Biologic/Genetic Mechanisms of Ovarian Cancer$15,000
R13 · FY2002 · CA
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS$129,202
K07 · FY2001 · CA
OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS$126,378
K07 · FY2000 · CA